🫀 Cardiovascular Update: CABG Boosts Survival, Polymer Valve Approved, PCSK9 Pill Succeeds and More
From revolutionary valves to powerful new therapies, this week’s cardiovascular update brings cutting-edge research straight to your screen. Dive into game-changing studies, regulatory milestones, and AI-driven monitoring tools that are shaping the future of heart health.
📌 In This Episode:
✔️ Surgical ablation during CABG extends survival in AF patients
✔️ India approves the world’s first polymer mitral valve—designed for young and childbearing-age patients
✔️ EuroPCR 2025: LuX-Valve Plus achieves a device success rate of greater than 95 percent in severe TR
✔️ South Korea launches Phase 3 trial for Amgen’s siRNA drug targeting elevated Lp(a)
✔️ Merck’s oral PCSK9 inhibitor enlicitide shows powerful LDL-C reductions in Phase 3 trials
✔️ New AI-enabling cardiac dataset enhances noninvasive monitoring
✔️ Abacavir use linked to higher cardiovascular risks in HIV therapy
✔️ Study exposes racial disparities in EMS care for cardiac arrest
✔️ Rare stroke mimic successfully treated—thrombosed aneurysm resected
Whether you’re a clinician, researcher, or just passionate about cardiovascular science—this roundup has something for you!
📢 Stay Ahead in Cardiovascular Research!
✅ Like, share, and subscribe for weekly updates on Cardiovascular breakthroughs
#Cardiology #HeartHealth #ClinicalTrials #MedicalInnovation #AFib #PCSK9 #ValveTherapy #EMSDisparities #HealthcareAI #LucidQuest #CardiovascularResearch #Lp(a) #StrokePrevention #MedicalBreakthroughs